107 related articles for article (PubMed ID: 23323585)
1. Clinical characteristics of intermediate uveitis in Chinese patients.
Chan CK; Wu ZH; Luk FO; Liu DT; Fan AH; Lee VY; Lai TY
Ocul Immunol Inflamm; 2013; 21(1):71-6. PubMed ID: 23323585
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of inflammatory cystoid macular edema.
Tranos PG; Tsaousis KT; Vakalis AN; Asteriades S; Pavesio CE
Retina; 2012 Sep; 32(8):1624-8. PubMed ID: 22481481
[TBL] [Abstract][Full Text] [Related]
3. Intermediate uveitis: long-term course and visual outcome.
Vidovic-Valentincic N; Kraut A; Hawlina M; Stunf S; Rothova A
Br J Ophthalmol; 2009 Apr; 93(4):477-80. PubMed ID: 19066184
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of intermediate uveitis in children.
de Boer J; Berendschot TT; van der Does P; Rothova A
Am J Ophthalmol; 2006 Apr; 141(4):616-21. PubMed ID: 16564794
[TBL] [Abstract][Full Text] [Related]
5. Intermediate uveitis in a pediatric Italian population.
Paroli MP; Spinucci G; Monte R; Pesci FR; Abicca I; Pivetti Pezzi P
Ocul Immunol Inflamm; 2011 Oct; 19(5):321-6. PubMed ID: 21970663
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
8. Visual and Clinical Outcome of Macular Edema Complicating Pediatric Noninfectious Uveitis.
Eiger-Moscovich M; Tomkins-Netzer O; Amer R; Habot-Wilner Z; Kasb A; Friling R; Kramer M
Am J Ophthalmol; 2019 Jun; 202():72-78. PubMed ID: 30772346
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of intermediate uveitis in Tunisian patients.
Khairallah M; Hmidi K; Attia S; Jelliti B; Hasnaoui W; Zaouali S; Jenzeri S; Yahia SB; Messaoud R
Int Ophthalmol; 2010 Oct; 30(5):531-7. PubMed ID: 20204460
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and visual outcome of intermediate uveitis in children.
Jain R; Ferrante P; Reddy GT; Lightman S
Clin Exp Ophthalmol; 2005 Feb; 33(1):22-5. PubMed ID: 15670074
[TBL] [Abstract][Full Text] [Related]
11. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
12. Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center.
Ness T; Boehringer D; Heinzelmann S
Orphanet J Rare Dis; 2017 Apr; 12(1):81. PubMed ID: 28449695
[TBL] [Abstract][Full Text] [Related]
13. Vitreous hemorrhage in multiple sclerosis-associated uveitis.
Valentincic NV; Kraut A; Rothova A
Ocul Immunol Inflamm; 2007; 15(1):19-25. PubMed ID: 17365802
[TBL] [Abstract][Full Text] [Related]
14. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
15. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
16. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.
Markomichelakis NN; Halkiadakis I; Pantelia E; Peponis V; Patelis A; Theodossiadis P; Theodossiadis G
Ophthalmology; 2004 May; 111(5):946-53. PubMed ID: 15121373
[TBL] [Abstract][Full Text] [Related]
17. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
18. Intermediate uveitis: comparison between childhood-onset and adult-onset disease.
Paroli MP; Abicca I; Sapia A; Bruschi S; Pivetti Pezzi P
Eur J Ophthalmol; 2014; 24(1):94-100. PubMed ID: 23813110
[TBL] [Abstract][Full Text] [Related]
19. Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome.
Heinz C; Schoonbrood S; Heiligenhaus A
Br J Ophthalmol; 2014 Aug; 98(8):1107-11. PubMed ID: 24713505
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab for choroidal neovascularization related to inflammatory diseases.
Kramer M; Axer-Siegel R; Jaouni T; Reich E; Hemo I; Priel E; Averbukh E; Ehrlich R; Chowers I; Weinberger D; Amer R
Retina; 2010 Jun; 30(6):938-44. PubMed ID: 20168273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
